Jiaweida Biotechnology key facts
- Opeartor of a biotechnology company focusing on the research and development, and production of biological raw materials.
- Notable investors include Changzhou Hi-tech Group, Hangzhou Huafang Chuangliang Investment Management, Holley Group.
- Status: Privately Held (backing).
Who backs Jiaweida Biotechnology
3- ·Watch Jiaweida Biotechnology: the Monday email on marks, rounds and moves
Jiaweida Biotechnology funding rounds
No funding rounds for Jiaweida Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Jiaweida Biotechnology investors
3 investors are on record for Jiaweida Biotechnology, including Changzhou Hi-tech Group, Hangzhou Huafang Chuangliang Investment Management and Holley Group.
About Jiaweida Biotechnology
Opeartor of a biotechnology company focusing on the research and development, and production of biological raw materials. The company is positioned as a research and development, production and sales of biological raw materials and synthetic biology products.
- Sector
- Healthcare
- HQ
- Wuhan, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Jiaweida Biotechnology doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.